On the call are Oliver Reichert, Director of Birkenstock Holding plc and Chief Executive Officer of the Birkenstock Group; ...

Alumis is firmly in focus after announcing positive topline results from two Phase 3 trials (ONWARD1 and ONWARD2) evaluating envudeucitinib , its next-generation oral TYK2 inhibitor, in ...

Tiger Gold Corp. (TSXV: TIGR) (“Tiger” or the “Company”) is pleased to announce that its common shares have commenced trading today ...

Tuesday, January 6, 2026 Happy New Year! And welcome back to MBN Agenda, our weekly look at the stories driving the news in the region and Washington. Brought to you by the Middle East ...